shutterstock_104778212.jpg

Research Overview

The Ottawa Allergy Research Corporation currently carries out Phase I, II, III, and IV clinical trials on behalf of pharmaceutical and biotechnology companies, as well as clinical research organizations.

OARC Services

Our services include:

  • recruiting participants and conducting Phase I, II, III and IV research studies;

  • recruiting patients and conducting patient role studies (compliance, preference, health status);

  • performing pharmacoeconomic evaluations;

  • providing pulmonary assessment technology;

  • storing drugs and documents securely; and

  • housing on-site laboratory and EKG facilities.

OARC advantage

The Ottawa Allergy Research Corporation is an active research facility with an outstanding record of excellence in clinical study.

When you work with us, you get:

  • extensive research experience;

  • skilled and knowledgeable staff;

  • top-quality data;

  • strong demographics; and

  • great facilities in a centralized location.

Study experience

Here’s a summary of the number and type of trials the Ottawa Allergy Research Corporation has managed to date.

  • Asthma / Allergic Asthma — 90

  • Seasonal Allergic Rhinitis (SAR) — 62

  • Hereditary Angioedema (HAE) — 31

  • Perennial Allergic Rhinitis (PAR) — 30

  • Chronic Obstructive Pulmonary Disease — 25

  • Chronic Idiopathic Urticaria — 16

  • Atopic Dermatitis — 14

  • Peanut allergy — 13

  • Polyposis — 7

  • Sinusitis — 7

  • Eosinophilic Esophagitis — 5

  • Osteoarthritis — 4

  • Rheumatoid Arthritis — 4

  • Vaccines (Bee/Cat/H1N1) — 4

  • Aspartame — 2

  • Common cold — 1

  • Conjunctivitis Disorders — 1

  • Chronic Bronchitis — 1

  • Essential Hypertension — 1

  • VMR — 1

  • MSG — 1

  • ABPA — 1

  • Cat Allergy — 1

  • Dust Mites — 1

  • Milk Allergy — 1

  • TOTAL — 324